Skip to Content

Early Immunologic Biomarker Predicts Renal Allograft Outcomes

FRIDAY, March 12, 2021 -- The ratio of interleukin-10 (IL-10) to tumor necrosis factor-α (TNFα) produced by transitional-1 B cells (T1B) predicts renal allograft outcomes, according to a study published in the Feb. 24 issue of Science Translational Medicine.

Aravind Cherukuri, M.B.B.S., Ph.D., from the University of Pittsburgh, and colleagues prospectively examined the ratio of IL-10/TNFα produced by T1B three months after renal transplantation as a predictive biomarker for 162 patients in a training set and 82 in an internal validation set.

The researchers found that the T1B IL-10/TNFα ratio at three months after transplantation predicted clinical and subclinical rejection in the first year. Subsequent late rejection was also predicted by the biomarker, with a lead time averaging eight months. Sixty percent of biomarker high-risk patients had early rejection, 48 percent of which recurred later in the first posttransplant year. Seventy-four percent of high-risk patients without early rejection developed rejection later in the first year. Among low-risk patients, 5 and 5 percent had early and late rejection, respectively. In an external validation set (95 patients) and in key patient subgroups, the biomarker predicted rejection. Compared with low-risk patients, biomarker high-risk patients exhibited progressively worse renal function and decreased five-year graft survival. Anti-TNFα treatment of B cells in vitro augmented the IL-10/TNFα ratio, restored regulatory activity, and inhibited plasmablast differentiation.

"The balance between IL-10 and TNF seems to indicate your immune setpoint -- is your immune system going to be quiescent or is it going to be revved up and try to reject the transplant? We hope we can restore that balance with anti-TNF drugs," a coauthor said in a statement.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Antibody Response to SARS-CoV-2 mRNA Vaccine Poor in Transplant Recipients

WEDNESDAY, March 24, 2021 -- Most solid organ transplant recipients do not mount an appreciable antibody response after receiving a first dose of mRNA severe acute respiratory...

Deceased Organ Donation Rose Among Blacks but Still Lags

TUESDAY, Feb. 23, 2021 -- Deceased organ donation increased among some racial groups, particularly among Black people, from 1999 to 2017, but substantial racial and ethnic...

Social Factors in Health Tied to Odds of Kidney Transplant

FRIDAY, Jan. 29, 2021 -- Social determinants of health and race are associated with the likelihood of undergoing kidney transplant, according to a study published online Jan. 28...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.